A detailed history of Washington Trust Advisors, Inc. transactions in Embecta Corp. stock. As of the latest transaction made, Washington Trust Advisors, Inc. holds 5 shares of EMBC stock, worth $70. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5
Previous 5 -0.0%
Holding current value
$70
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 18, 2023

SELL
$15.0 - $22.17 $75 - $110
-5 Reduced 50.0%
5 $0
Q3 2022

Oct 14, 2022

SELL
$24.0 - $33.42 $840 - $1,169
-35 Reduced 77.78%
10 $0
Q2 2022

Jul 25, 2022

BUY
$24.78 - $33.36 $1,115 - $1,501
45 New
45 $1,000

Others Institutions Holding EMBC

About Embecta Corp.


  • Ticker EMBC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 57,836,500
  • Market Cap $820M
  • Description
  • Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...
More about EMBC
Track This Portfolio

Track Washington Trust Advisors, Inc. Portfolio

Follow Washington Trust Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Washington Trust Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Washington Trust Advisors, Inc. with notifications on news.